These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26049118)

  • 1. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.
    Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA
    Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
    Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
    FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
    Gursky O; Mei X; Atkinson D
    Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' peptide in the sequence of the highly amyloidogenic human calcitonin.
    Iconomidou VA; Leontis A; Hoenger A; Hamodrakas SJ
    FEBS Lett; 2013 Mar; 587(6):569-74. PubMed ID: 23395606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
    Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
    J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An N-terminal pro-atrial natriuretic peptide (NT-proANP) 'aggregation-prone' segment involved in isolated atrial amyloidosis.
    Louros NN; Iconomidou VA; Tsiolaki PL; Chrysina ED; Baltatzis GE; Patsouris ES; Hamodrakas SJ
    FEBS Lett; 2014 Jan; 588(1):52-7. PubMed ID: 24220659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural studies and cytotoxicity assays of "aggregation-prone" IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin.
    Louros NN; Tsiolaki PL; Zompra AA; Pappa EV; Magafa V; Pairas G; Cordopatis P; Cheimonidou C; Trougakos IP; Iconomidou VA; Hamodrakas SJ
    Biopolymers; 2015 May; 104(3):196-205. PubMed ID: 25913357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid fibrils formed by selective N-, C-terminal sequences of mouse apolipoprotein A-II.
    Sawashita J; Kametani F; Hasegawa K; Tsutsumi-Yasuhara S; Zhang B; Yan J; Mori M; Naiki H; Higuchi K
    Biochim Biophys Acta; 2009 Oct; 1794(10):1517-29. PubMed ID: 19596087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I induced amyloidosis.
    Genschel J; Haas R; Pröpsting MJ; Schmidt HH
    FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice.
    Sawashita J; Zhang B; Hasegawa K; Mori M; Naiki H; Kametani F; Higuchi K
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E836-45. PubMed ID: 25675489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
    Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure.
    Lazar KL; Miller-Auer H; Getz GS; Orgel JP; Meredith SC
    Biochemistry; 2005 Sep; 44(38):12681-9. PubMed ID: 16171382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
    Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
    Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils.
    Adachi E; Kosaka A; Tsuji K; Mizuguchi C; Kawashima H; Shigenaga A; Nagao K; Akaji K; Otaka A; Saito H
    FEBS Lett; 2014 Jan; 588(3):389-94. PubMed ID: 24316228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
    Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
    J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures.
    Townsend D; Hughes E; Hussain R; Siligardi G; Baldock S; Madine J; Middleton DA
    Biochemistry; 2017 Mar; 56(11):1632-1644. PubMed ID: 27992182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.
    Obici L; Bellotti V; Mangione P; Stoppini M; Arbustini E; Verga L; Zorzoli I; Anesi E; Zanotti G; Campana C; Viganò M; Merlini G
    Am J Pathol; 1999 Sep; 155(3):695-702. PubMed ID: 10487826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.
    Monti DM; Guglielmi F; Monti M; Cozzolino F; Torrassa S; Relini A; Pucci P; Arciello A; Piccoli R
    Eur Biophys J; 2010 Aug; 39(9):1289-99. PubMed ID: 20182709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.